Steffen Schuster is the founder of Isotopen Technologien München. Isotopen Technologien München has raised $235M in total funding. Latest round: Series C.
Steffen Schuster is the Chief Executive Officer of ITM AG, a radiopharmaceutical company focused on developing and supplying radiotherapeutics and diagnostics for cancer treatment. He has commented on the company's funding rounds, highlighting the commitment of investors to advancing precision oncology.
Full founder directory · Investor directory · Company funding database · Fundraising library